Market Overview

Johnson & Johnson Breaks Out Over $75 Resistance

Share:
Related JNJ
Morgan Stanley Analyst Sees FY15 'Trough' For Johnson & Johnson Pharma Growth
Why Minerva Neurosciences Is Trading Higher
Making Money With Charles Payne: 01/21/15 (Fox Business)

Posted-In: Technicals Trading Ideas

 

Related Articles (JNJ)

Around the Web, We're Loving...

Get Benzinga's Newsletters